Dr Reddy’s

Showing 15 posts of 23 posts found.


Dr Reddy’s demand more than $70 million from Indivior over generic Suboxone Film

March 12, 2019
Manufacturing and Production Dr Reddy's, Suboxone Film, court, indivior, opioid addiction

Indian firm Dr Reddy’s is seeking at least $70 million from British firm Indivior Plc as compensation for lost sales …


Indivior launches authorised generic version of opioid addiction treatment Suboxone as rival generic drugmakers enter market

February 21, 2019
Sales and Marketing Alvogen, Dr Reddy's, Novartis, Sandoz, indivior

Indivior has announced the launch of an authorised generic version of Suboxone Film (buprenorphine/naloxone) a combination medicine used to treat …

Generics firms investigated for their involvement in the ‘largest cartel in the history of the United States’

December 11, 2018
Manufacturing and Production Dr Reddy's, Mylan, Teva, US, corruption, generics, price fixing, price-fixing, sun

At least 16 generic drugmakers are being investigated for their involvement in what has been described as the “largest cartel …


Dr Reddy’s just-approved opioid dependence generic blocked over US patent dispute

June 18, 2018
Sales and Marketing Dr Reddy's, FDA, Mylan, US, opioid crisis, opioid dependence, opioids, suboxone

Dr Reddy’s Laboratories has taken two steps forward an one step back after its generic version of Suboxone Film (buprenorphine/naloxone) …


Dr Reddy’s hit by yet another recall, of 80,000+ bottles

February 8, 2018
Sales and Marketing Dr Reddy's, FDA, biotech, drugs, pharma, pharmaceutical

Dr Reddy’s Laboratories problem with ensuring products reach the market at a quality the FDA deems acceptable is no secret …


Court fines Dr Reddy’s for improperly packaging products

January 22, 2018
Sales and Marketing Dr Reddy's, biotech, drugs, pharma, pharmaceutical

On 18 December 2017, the District of New Jersey filed a complaint against Dr. Reddy’s Laboratories for failing to comply …


Dr Reddy’s gets greenlight to market Doxil generic

May 18, 2017
Sales and Marketing Dr Reddy's, FDA

Dr Reddy’s Laboratories, one of India’s largest pharmaceutical firms, has revealed that the FDA has given the go-ahead to market …


13 FDA observations on Dr Reddy’s plant send shares to 3 year low

March 9, 2017
Manufacturing and Production Dr Reddy's, FDA

Indian pharmaceutical firm Dr Reddy’s has seen its shares drop on the Bombay Stock Exchange to their lowest point in …


India’s NPPA identifies 634 non-compliant drug pricings

February 24, 2017
Medical Communications, Sales and Marketing Abbott, AstraZeneca, Cipla, Dr Reddy's, Dr Reddy’s, nppa

India’s National Pharmaceutical Pricing Authority (NPPA) has revealed that as many as 634 drugs from top pharma firms in the …


India-based Cipla gets new chief financial officer

June 8, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cipla, Dr Reddy's, cfo, dr reddys

Cipla (NSE: CIPLA) has poached a top executive from Dr. Reddy’s by naming Kedar Upadhye as its new global chief …

Dr Reddy's generic nexium

Dr Reddy’s relaunches generic Nexium in blue after AstraZeneca lawsuit

January 6, 2016
Manufacturing and Production, Sales and Marketing AstraZeneca, Dr Reddy's, Nexium, acid reflux, esomeprazole, lawsuit, purple pill

Dr Reddy’s has relaunched its generic version of AstraZeneca’s blockbuster heartburn drug Nexium  in the US, changing the colour from …

FDA warnings create woe for Indian drugmakers

November 10, 2015
Manufacturing and Production CGMP, Dr Reddy's, Dr. Reddy's, FDA, India, Sun Pharma, manufacturing, production

Recent enforcement action has taken its toll on the fortunes of several Indian pharmaceutical manufacturers, with Sun Pharmaceuticals and Dr. …

Novartis image

AZ triumphs in Nexium pay-for-delay trial

December 8, 2014
Sales and Marketing AstraZeneca, Dr Reddy's, Nexium, Ranbaxy, dr reddys, esomeprazole

AstraZeneca and Ranbaxy have avoided what might have been a $10 billion pay out regarding delays to the generic version …

Dr Reddy's image

Dr Reddy’s recalls blood pressure drug

June 20, 2014
Manufacturing and Production Dr Reddy's, India, blood pressure, metoprolol succinate, recall, toprol

Indian generics manufacturer Dr Reddy’s Laboratories is in the midst of recalling more than 13,000 bottles of blood pressure medicine …

Latest content